YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Seeing the Light Narrows Drug Candidates


July | August 2006 | Applied Biosystems and MDS Sciex announced global availability of a drug discovery application that enables pharmaceutical companies and contract research organizations to more quickly and accurately screen drug candidates. The application, LightSight Software for Metabolite Identification, improves productivity and efficiency of drug discovery scientists analyzing new compounds to treat human disease. This metabolite ID solution enables drug discovery scientists to more quickly examine thousands of drug candidates and determine those that meet the requirements for further development. Companies can then focus valuable resources with greater accuracy on the most promising drug candidates.

Vendor: Applied Biosystems/MDS Sciex

Product: LightSight Software for Metabolite Identification

Availability: Now

For more information: www.appliedbiosystems.com

View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.